The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner - Seite 2

Half of the portfolio will focus on enabling healthier lives and producing better foods. The other half will address reducing chemical use and targeting climate neutral practices.

The combined group will operate a global network of R&D and application centers as well as manufacturing sites and will employ around 10,000 talented and purpose-driven employees who are inspired by the power of biosolutions.

The name ’Novonesis’ has origin in science’s classical roots  ‘Genesis’ is Greek for ‘origin’ or ‘beginning’. By choosing a word with a root in Greek the name honors how ancient Greek thinkers (from Pythagoras to Aristotle) played a key role in the development of science as we know it today.   ‘Novo’ means new. The Novo name is globally associated with strong science capabilities, a purpose driven mindset, a Nordic heritage as well as a great societal contributor. These are all assets and values that are shared by the future combined company.

Financial ambitions as communicated on December 12, 2022

• An expected organic revenue growth of 6-8% (CAGR) through 2025.²
• An expected EBIT margin of 29% by 2025 excluding integration costs and PPA amortization.³
• Annual revenue synergies are estimated at EUR 200 million with an EUR 80-90 million EBIT impact achievable within four years of completion and an estimated EUR 80-90 million in cost synergies achievable within three years of completion.
• Beyond 2025, the ambition is to continue to deliver accelerated sustainable growth from the underlying business coupled with new, and de-risked, innovation and growth opportunities.
• EPS, excluding integration costs and PPA amortization, is expected to be mid-single digit percentage accretive in the third year of completion.
• No additional debt is expected to be issued because of the transaction, and leverage at completion is expected to be 1.3-1.7x, which is also the expected future net debt level.
• A continuation of historic shareholder dividend payout ratio of ~50% is expected.

Sustainability ambitions as communicated on December 12, 2022